Evidence map›Paper›PMID 34200994›Full record

ArticleCancers2021

Coordinating Effect of VEGFC and Oleic Acid Participates to Tumor Lymphangiogenesis.

Florent Morfoisse, Fabienne De Toni, Jeremy Nigri, Mohsen Hosseini, Audrey Zamora, Florence Tatin, Françoise Pujol, Jean-Emmanuel Sarry, Dominique Langin, Eric Lacazette and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Florent MorfoisseI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.ORCID 0000-0003-1532-3665
Fabienne De ToniI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.
Jeremy NigriCRCM, Inserm UMR 1068, 13001 Marseille, France.ORCID 0000-0003-1358-1863
Mohsen HosseiniCRCT, Université de Toulouse, Inserm UMR 1037, UPS, 31000 Toulouse, France.
Audrey ZamoraI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.
Florence TatinI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.
Françoise PujolI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.
Jean-Emmanuel SarryCRCT, Université de Toulouse, Inserm UMR 1037, UPS, 31000 Toulouse, France.
Dominique LanginI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.ORCID 0000-0002-2669-7825
Eric LacazetteI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.ORCID 0000-0003-1234-5260
Anne-Catherine PratsI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.ORCID 0000-0002-5282-3776
Richard TomasiniCRCM, Inserm UMR 1068, 13001 Marseille, France.ORCID 0000-0003-0869-0811
Jean GalitzkyI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.
Anne BouloumiéI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.
Barbara Garmy-SusiniI2MC, Université de Toulouse, Inserm UMR 1297, UPS, 31000 Toulouse, France.ORCID 0000-0001-6100-2294
Université Toulouse III - Paul Sabatier · FRInserm · FR

Funding

Association pour la Recherche sur le Cancer RPH21002BBAHorizon 2020 Framework Programme EEA20001BBAligue contre le cancer R21019BBrégion midi-pyrénées FEDER R19001BB
6 · The paper itself

Abstract

In cancer, the lymphatic system is hijacked by tumor cells that escape from primary tumor and metastasize to the sentinel lymph nodes. Tumor lymphangiogenesis is stimulated by the vascular endothelial growth factors-C (VEGFC) after binding to its receptor VEGFR-3. However, how VEGFC cooperates with other molecules to promote lymphatics growth has not been fully determined. We showed that lymphangiogenesis developed in tumoral lesions and in surrounding adipose tissue (AT). Interestingly, lymphatic vessel density correlated with an increase in circulating free fatty acids (FFA) in the lymph from tumor-bearing mice. We showed that adipocyte-released FFA are uploaded by lymphatic endothelial cells (LEC) to stimulate their sprouting. Lipidomic analysis identified the monounsaturated oleic acid (OA) as the major circulating FFA in the lymph in a tumoral context. OA transporters FATP-3, -6 and CD36 were only upregulated on LEC in the presence of VEGFC showing a collaborative effect of these molecules. OA stimulates fatty acid β-oxidation in LECs, leading to increased AT lymphangiogenesis. Our results provide new insights on the dialogue between tumors and adipocytes via the lymphatic system and identify a key role for adipocyte-derived FFA in the promotion of lymphangiogenesis, revealing novel therapeutic opportunities for inhibitors of lymphangiogenesis in cancer.

Indexed as

FFAlymphaticoleic acid

Identifiers

PMID34200994
PMCPMC8227717
OpenAlexW3168250348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.